BackCBD Life Sciences Overview

CBD Life Sciences Current Assets

Latest current assets for CBDL: $520K.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$515545.00

Peer trimmed avg / median

Loading

CBD Life Sciences Current Assets History

Loading

CBD Life Sciences vs. peers: Current Assets Comparison

Loading

CBD Life Sciences Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

CBD Life Sciences (CBDL) FAQ

CBD Life Sciences posts a current assets of $520K as of June 2026. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

Current Assets is one piece of CBD Life Sciences's financial statement story. At $520K, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for CBDL's current assets usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; CBD Life Sciences's other metric pages and overview cover the third.